The goal of tissue engineering is to mitigate the critical shortage of donor organs via in vitro fabrication of functional biological structures. Tissue engineering is one of the most prominent examples of interdisciplinary fields, where scientists with different backgrounds work together to boost the quality of life by addressing critical health issues. Many different fields, such as developmental and molecular biology, as well as technologies, such as micro- and nanotechnologies and additive manufacturing, have been integral for advancing the field of tissue engineering. Over the past 20 years, spectacular advancements have been achieved to harness nature's ability to cure diseased tissues and organs. Patients have received laboratory-grown tissues and organs made out of their own cells, thus eliminating the risk of rejection. However, challenges remain when addressing more complex solid organs such as the heart, liver, and kidney. Herein, we review recent accomplishments as well as challenges that must be addressed in the field of tissue engineering and provide a perspective regarding strategies in further development.
Bioprinters are being extensively used for different applications in life sciences and medicine in general and more specifically in regenerative medicine, tissue, and organ fabrication. The technology has matured from its purely academic origin owing to the involvement of materials science, engineering, biology, and physics, as well as commercial entities. Nevertheless, despite the progress in the science and the understanding of the mechanisms underlying the various bioprinting technologies, further efforts are needed to develop more quantitative strategies. In particular, predictive modeling is necessary to optimize the printing parameters and thus enhance the quality of the final products. Here, we review the physics that underpins the most commonly employed approaches, such as extrusion, laser-based, and inkjet bioprinting. We provide an overview of the relevant parameters, their inter-relationships, and the equations that govern the various printing processes and thus allow for their optimization. We present our perspective on the field and views on future strategies for its further advancement. Our intention with this review is to provide the practitioners of bioprinting with additional tools to enhance the quantitative aspects of their work and move the technology beyond its early, mostly “trial and error” character.
The number of patients requiring organ transplantations is exponentially increasing. New organs are either provided by healthy or deceased donors, or are grown in laboratories by tissue engineers. ...
Over the past ten years, tissue engineering has witnessed significant technological and scientific advancements. Progress in both stem cell science and additive manufacturing have established new horizons in research and are poised to bring improvements in healthcare closer to reality. However, more sophisticated indications such as the scale-up fabrication of biological structures (e.g., human tissues and organs) still require standardization. To that end, biocompatible electronics may be helpful in the biofabrication process. Here, we report the results of our systematic exploration to seek biocompatible/degradable functional electronic materials that could be used for electronic device fabrications. We investigated the electronic properties of various biomaterials in terms of energy diagrams, and the energy band gaps of such materials were obtained using optical absorption spectroscopy. The main component of an electronic device is manufactured with semiconductor materials (i.e., Eg between 1 to 2.5 eV). Most biomaterials showed an optical absorption edge greater than 2.5 eV. For example, fibrinogen, glycerol, and gelatin showed values of 3.54, 3.02, and 3.0 eV, respectively. Meanwhile, a few materials used in the tissue engineering field were found to be semiconductors, such as the phenol red in cell culture media (1.96 eV energy band gap). The data from this research may be used to fabricate biocompatible/degradable electronic devices for medical applications.
Melanin is a natural biopigment that is produced by melanocytes and can be found in most living organisms. The unique physical and chemical properties of melanin render it potentially useful for numerous applications, particularly those in which a biocompatible functional material is required. Herein, we introduce one important technology in which melanin can be utilized: a drug delivery system in terms of a biocompatible matrix. However, extracting melanin from different biological sources is costly and time-consuming and introduces variabilities in terms of chemical structure, properties, and functions. Hence, a functionally reproducible system is hard to achieve using biologically extracted melanin. Here we report the synthesis of melanin nanoparticles of controlled uniform sizes and chemical characteristics. The optical, chemical, and structural characteristics of synthesized nanoparticles were characterized by optical confocal photoluminescence (PL) imaging, scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), and Zeta potentiometry. The melanin nanoparticles have 100 nm size and a narrow size distribution. The advantage of a nanoparticle structure is its enhanced surface-to-volume ratio compared to bulk pigments, which is important for applications in which controlling the microscopic surface area is essential. Using the inkjet printing technique, we developed melanin thin films with minimum ink waste and loaded them with methylene blue (our representative drug) to test the drug-loading ability of the melanin nanoparticles. Inkjet printing allowed us to create smooth uniform films with precise deposition and minimum ink-waste. The spectroscopic analysis confirmed the attachment of the “drug” onto the melanin nanoparticles as a matrix. Hence, our data identify melanin as a material system to integrate into drug release applications.